Michael Zdanowski
Corporate Officer/Principal at Medeor Therapeutics, Inc.
Net worth: 2 352 $ as of 2024-04-29
Network origin in Michael Zdanowski first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Extinct | Pharmaceuticals: Major | 10 | |
New York Stem Cell Foundation, Inc.
9
| Foundation/Endowment | Investment Trusts/Mutual Funds | 9 |
Medeor Therapeutics, Inc.
 Medeor Therapeutics, Inc. Medical/Nursing ServicesHealth Services Medeor Therapeutics, Inc. engages in medical industry. It provides services which are dedicated to the discovery, development, and commercialization of transformative and personalized cellular therapeutics. The company was founded by Samuel Strober, Edgar Engleman, Robert Lowsky, and Chih Ping in 2012 and is headquartered in South San Francisco, CA.
4
| Holding Company | Medical/Nursing Services | 4 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Michael Zdanowski via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| THE GOLDMAN SACHS GROUP, INC. | Investment Banks/Brokers | Compliance Officer Corporate Officer/Principal | |
| ACCELERON PHARMA INC. | Biotechnology | Chairman Director/Board Member | |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Ivenix, Inc.
 Ivenix, Inc. Medical SpecialtiesHealth Technology Ivenix, Inc. operates as a medical device company. It develops and supplies infusion systems and intravenous-infusion pumps that eliminate air in the fluid bag line. The company was founded by John L. Bakos and Jeffrey Carlisle in 2007 and is headquartered in Amesbury, MA. | Medical Specialties | Director/Board Member | |
| ALTHEADX INC | Pharmaceuticals: Major | Chief Executive Officer | |
| AURA BIOSCIENCES, INC. | Biotechnology | Director/Board Member | |
Abide Therapeutics, Inc.
 Abide Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Abide Therapeutics, Inc. develops medicines that target serine hydrolases. Its approach is to selectively block serine hydrolases, potentially expanding this class of commercially validated enzymes as targets in a range of indications. The firm has a technology platform that exploits a chemoproteomics approach to selectively target serine hydrolases and rapidly identify target lead pairs. The company was founded by Alan B. Ezekowitz, Dale Boger, John Kennedy Clarke, Benjamin F. Cravatt, Todd Jones, Keith F. Lenden, and Paul R. Schimmel in 2011 and is headquartered in San Diego, CA. | Pharmaceuticals: Other | Director of Finance/CFO | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree | |
Condé Nast Entertainment, Inc.
 Condé Nast Entertainment, Inc. Movies/EntertainmentConsumer Services Condé Nast Entertainment, Inc. develops film, television, and premium digital video programming. The firm's portfolio include Vogue, Vanity Fair, Glamour, Brides, Self, GQ, GQ Style, The New Yorker, Condé Nast Traveler, Allure, Architectural Digest, Bon Appétit, Epicurious, Wired, W, Golf Digest, Golf World, Teen Vogue, Ars Technica, The Scene, Pitchfork and Backchannel. The company was founded by Conde Montrose Nast and Pat Connolly in 2011 and is headquartered in New York, NY. | Movies/Entertainment | Public Communications Contact | |
| INNOVIVA, INC. | Pharmaceuticals: Major | Director/Board Member | |
| American University | College/University | Undergraduate Degree | |
| University of Toronto | College/University | Undergraduate Degree Graduate Degree | |
Robert W. Baird & Co., Inc. /Venture Partners/
 Robert W. Baird & Co., Inc. /Venture Partners/ Investment ManagersFinance Robert W. Baird & Co., Inc./Venture Partners/ (Baird Venture) is a venture capital division of Robert W. Baird & Co., Inc. founded in 2000 by Thomas Desmond. The firm is headquartered in Chicago, Illinois. | Investment Managers | Private Equity Investor | |
Eight Roads Capital Advisors (Hong Kong) Ltd.
 Eight Roads Capital Advisors (Hong Kong) Ltd. Investment ManagersFinance Eight Roads Capital Advisors (Hong Kong) Ltd(Eight Roads Capital) is a venture capital firm founded in 1900. Headquartered in Hong Kong. | Investment Managers | Corporate Officer/Principal | |
Merck Serono SA
 Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | Medical Specialties | Market Strategist | |
Connecticut Business & Industry Association
 Connecticut Business & Industry Association Miscellaneous Commercial ServicesCommercial Services Connecticut Business & Industry Association is a non-profit organization that provides commercial support services. The private company is based in Hartford, CT. Joseph F. Brennan has been the CEO of the company since 1988. | Miscellaneous Commercial Services | Director/Board Member | |
ModernaTX, Inc.
 ModernaTX, Inc. BiotechnologyHealth Technology Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA. | Biotechnology | Founder | |
| China University of Science & Technology | College/University | Undergraduate Degree | |
| INNOVENT BIOLOGICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Kellogg School of Management | College/University | Masters Business Admin | |
Impresa Management LLC
 Impresa Management LLC Investment ManagersFinance Impresa Management LLC(Impresa Management) is a Private Equity/Venture Capital firm, a subsidiary of Devonshire Investors LLC founded in 1946.The firm is headquartered in Boston. | Investment Managers | Private Equity Investor | |
6 Dimensions Capital
 6 Dimensions Capital Investment ManagersFinance 6 Dimensions Capital is an independent private equity firm headquartered in China. The firm was founded in 2017. | Investment Managers | Private Equity Investor | |
| INTELLIA THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO Founder | |
Shanghai Fangrun Medical Technology Co., Ltd.
 Shanghai Fangrun Medical Technology Co., Ltd. Electronic Equipment/InstrumentsElectronic Technology Forerunner Medical Equipment Technology Shanghai Co. Ltd. engages in the manufacture, sale of pharmaceutical products and medical equipment. The company was founded by Jie Qin in 2009 and is headquartered in Shanghai, China. | Electronic Equipment/Instruments | Director/Board Member | |
| ONCORUS, INC. | Biotechnology | Director/Board Member | |
| CSTONE PHARMACEUTICALS | Pharmaceuticals: Major | Director/Board Member | |
eGenesis, Inc.
 eGenesis, Inc. Miscellaneous Commercial ServicesCommercial Services eGenesis, Inc. operates research platform to deliver human transplantable cells, tissues, and organs grown in pigs. It uses gene editing technology such as CRISPR to directly address the key virology and immunology hurdles that have impeded xenotransplantation. The company was founded by George M. Church, Yang Luhan, Prashant Mali, Geoff Mackay and Guell Marc in 2015 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director of Finance/CFO | |
LifeMine Therapeutics, Inc.
 LifeMine Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LifeMine Therapeutics, Inc. develops drugs from fungi which aims to cure untreatable and significant chronic diseases. The company was founded by Gregory L. Verdine, WeiQing Zhou, Richard D. Klausner and Hingge Hsu and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
| TCR2 THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member | |
| KYMERA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| MODERNA, INC. | Biotechnology | Director/Board Member Founder | |
Dewpoint Therapeutics, Inc.
 Dewpoint Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Dewpoint Therapeutics, Inc. develops drugs. The company is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member | |
| OCUMENSION THERAPEUTICS | Pharmaceuticals: Major | Director/Board Member | |
Creacion Ventures Management LLC
 Creacion Ventures Management LLC Investment ManagersFinance Creacion Ventures Management LLC (Creacion Ventures) is a venture capital firm founded in 2020. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor | |
| Creacion Ventures GP I LLC | Corporate Officer/Principal | ||
| NUVALENT, INC. | Biotechnology | Director/Board Member | |
| CULLINAN THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
Alumis, Inc.
 Alumis, Inc. Pharmaceuticals: MajorHealth Technology Alumis, Inc. is a precision medicines company called Esker that aims to provide personalized treatments for people with autoimmune diseases. The company is based in San Francisco, CA. Esker uses a precision analytics platform, powered by foresite labs, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology to create medicines that change the lives of people with autoimmune disease. The company was founded by June H Lee. Martin Babler has been the CEO of the company since 2021. | Pharmaceuticals: Major | Director/Board Member | |
| SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. II | Financial Conglomerates | Director/Board Member | |
| BIOPLUS ACQUISITION CORP. | Financial Conglomerates | Corporate Officer/Principal | |
Frontera Therapeutics, Inc.
 Frontera Therapeutics, Inc. BiotechnologyHealth Technology Frontera Therapeutics, Inc. is an American biotechnology company that focuses on the research and development of innovative drugs for various diseases such as eye, blood, genetic metabolism, neuromuscular, and others. The company is based in Shanghai, China, and has subsidiaries in Suzhou, China. Frontera Therapeutics specializes in producing high-quality and affordable recombinant adeno-associated virus (rAAV) carrier gene therapy products to meet the treatment needs of hereditary and chronic diseases. The company was founded in September 2019 by Hongyuan Capital and Obo Capital Investment, and it brings together professionals with rich experience in drug research and development, clinical research, registration, and production management. | Biotechnology | Director/Board Member | |
| Jp Morgan Direct Corporate Finance | Corporate Officer/Principal | ||
| New York University School of Medicine | College/University | Doctorate Degree | |
Semma Therapeutics, Inc.
 Semma Therapeutics, Inc. BiotechnologyHealth Technology Semma Therapeutics, Inc. develops transformative therapies for patients who currently depend on insulin injections. It focuses on combining proprietary cells with a state-of-the-art device to provide a true replacement for the missing beta cells in a diabetic patient without immunosuppression. The company was founded by Robert A. Millman, Walter A. Blättler, Felicia Pagliuca, Jeff Imbaro and Douglas A. Melton in 2015 and is headquartered in Cambridge, MA. | Biotechnology | Director of Finance/CFO |
Statistics
International
| United States | 40 |
| China | 5 |
| Cayman Islands | 3 |
| Canada | 2 |
| Hong Kong | 2 |
Sectoral
| Health Technology | 28 |
| Finance | 9 |
| Consumer Services | 8 |
| Commercial Services | 5 |
| Electronic Technology | 2 |
Operational
| Director/Board Member | 143 |
| Independent Dir/Board Member | 44 |
| Corporate Officer/Principal | 44 |
| Chairman | 27 |
| Chief Executive Officer | 25 |
Most connected contacts
| Insiders | |
|---|---|
| Paul Meister | 43 |
| Nicholas G. Galakatos | 38 |
| Karen Smith | 29 |
| Francois Nader | 28 |
| Wei Li | 24 |
| Frank Kung | 22 |
| Sapna R. Srivastava | 22 |
| Giovanni A. Ferrara | 15 |
| Stephen Scherr | 14 |
| Mary Fenton | 10 |
| Derrick J. Rossi | 10 |
| Gaurav D. Shah | 8 |
| Andrew Farnsworth | 8 |
| Douglass H. Laidlaw | 5 |
| Colby Suire | 4 |
- Stock Market
- Insiders
- Michael Zdanowski
- Company connections
